Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?

Table 1

Demographic characteristics of patient groups.

Variable	Prophylaxis with fosfomycin trometamol (n=35)	Prophylaxis with phytodrug (n=37)	p
Age (years)	62.7 ±11.2	63.8 ±10.8	NS
BMI (kg/m^2)	30.1 ±3.8	30.2 ±4	NS
Parity	2.1 ±1.12	2.3 ±0.97	NS
Menopause	28 (80%)	31 (83.7%)	NS

Continuous variables are presented as the mean±SD; categorical variables are presented as number and %.